短腸症候群の日本人患者におけるテドグルチドの研究

基本情報

NCT ID

NCT05023382

ステータス

募集中

試験のフェーズ

-

試験タイプ

観察

目標被験者数

120

治験依頼者名

Takeda

概要

The main aims of this study are to check for side effects from treatment with teduglutide (Revestive) and how well teduglutide controls symptoms of short bowel syndrome. The study sponsor will not be involved in how the participants are treated but will provide instructions on how the clinics will record what happens during the study. During the study, participants with short bowel syndrome will receive an injection of teduglutide just under the skin (subcutaneous) according to their clinic's standard practice. The study doctors will check for side effects from teduglutide for 36 months.

対象疾患

介入

依頼者（Sponsor）